| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.26B | 85.21B | 82.05B | 85.33B | 78.65B | 81.65B |
| Gross Profit | 18.07B | 18.39B | 18.04B | 18.76B | 17.40B | 18.68B |
| EBITDA | 2.88B | 3.31B | 3.99B | 3.88B | 3.29B | 3.54B |
| Net Income | 759.00M | 1.10B | 1.31B | 1.48B | 939.00M | 626.00M |
Balance Sheet | ||||||
| Total Assets | 103.15B | 102.23B | 103.29B | 102.16B | 98.30B | 98.51B |
| Cash, Cash Equivalents and Short-Term Investments | 16.54B | 14.74B | 18.68B | 21.78B | 22.22B | 22.39B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 27.66B | 25.94B | 28.11B | 29.26B | 25.53B | 25.43B |
| Stockholders Equity | 75.48B | 76.28B | 75.18B | 72.90B | 72.78B | 73.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.69B | -2.07B | 2.46B | 2.33B | 4.16B |
| Operating Cash Flow | 0.00 | -423.00M | -210.00M | 3.67B | 3.58B | 6.05B |
| Investing Cash Flow | 0.00 | -2.75B | -345.00M | -874.00M | -1.41B | -1.82B |
| Financing Cash Flow | 0.00 | -817.00M | -863.00M | -816.00M | -815.00M | -959.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥15.36B | 11.39 | ― | 2.30% | 9.86% | 119.10% | |
81 Outperform | ¥21.66B | 9.13 | ― | 3.46% | 3.87% | 5.89% | |
80 Outperform | ¥41.22B | 12.24 | ― | 2.52% | 2.47% | 6.88% | |
69 Neutral | ¥37.15B | 7.23 | ― | 2.83% | 2.27% | 24.78% | |
66 Neutral | ¥67.55B | 32.66 | 1.51% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥27.94B | 39.92 | ― | 2.94% | 0.41% | -51.02% |